Jan 21, 2011 · The new guideline advocates use of plasmapheresis for treatment of severe relapses in multiple sclerosis, severe AIDP/Guillain-Barre syndrome, and short-term management of CIDP.
Although HAART is reducing opportunistic diseases, neurologic manifestations due to HIV itself impose huge burdens on patients, families, and healthcare resources in India.
Feb 3, 2026 · Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
